Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam Dose Escalation for Neonatal Seizures
NCT05610085Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Mar 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of levetiracetam in seizure, neonatal encephalopathy (NE), hypoxic-ischemic encephalopathy (HIE), sponsored by University of California, San Diego. Started Mar 2023; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
seizureneonatal encephalopathy (NE)hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT05610085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610085.